Meiji Holdings Co., Ltd. · TSE:2269

Meiji — FY2011 Earnings Presentation

16 slides from Meiji's earnings presentation, May 21, 2012

  1. Slide 1: Appendix

    Appendix 1. FY2011 Consolidated Financial Review 2. - Forecasts for FY2012 -

  2. Slide 2: 1. FY2011 Consolidated Financial Review

    1. FY2011 Consolidated Financial Review [Appendix] 2 2012.05.21 Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved.

  3. Slide 3: FY2011: Analysis of Consolidated Operating Income

    FY2011: Analysis of Consolidated Operating Income (billions of yen) Full-year Results (by Segment) Plan Food Pharma Other FY2010 29.9 22.3 7.5 0.2 29.9 Due to increased/decreased sales -2.6 (Note2) -5.2 +2.6 - -5.6 Procurement costs of raw materials -2.8 -2.8 0 - -3.0 Depreciation -0.8 -0.8 0 - -0.8

  4. Slide 4: FY2011: Results by Segment

    FY2011: Results by Segment (billions of yen) 1st Half 2nd Half Full-year YoY vs. Plan on YoY vs. Plan on YoY vs. Plan on change May 12 change Feb. 13 change Feb. 13 -2.4% +3.2% +2.0% +0.8% -0.3% +0.4% Net sales 490.5 (-12.0) (+14.9) 495.7 (+9.5) (+3.9) 986.3 (-2.5) (+3.9) Food -79.6% -31.7% -4.7% +2

  5. Slide 5: FY2011: Consolidated Balance Sheet

    FY2011: Consolidated Balance Sheet YoY YoY As of Mar. 31, 2012 Results change As of Mar. 31, 2012 Results change Current assets 322.5 +20.8 Current liabilities 352.5 +51.1 Cash and deposits 14.6 -7.0 Accounts payable 109.1 +16.9 Notes and accounts receivable 168.6 +22.3 Debts (finance) 150.1 +39.9 I

  6. Slide 6: FY2011: Consolidated Financial Indices and Cash Flows

    FY2011: Consolidated Financial Indices and Cash Flows (billions of yen) FY2010 FY2011 YoY change Earning per share (EPS) 129.63 yen 92.38 yen -37.25 yen Return on equity (ROE) 3.3% 2.3% -1.0 pts Cash flows from operating activities…(1) 57.9 30.5 -27.3 Cash flows from investing activities…(2) -32.4 -

  7. Slide 7: FY2011: Capital Expenditures, Depreciation, R&D Expenses

    FY2011: Capital Expenditures, Depreciation, R&D Expenses (billions of yen) FY2011 Notes Food Pharma Capital expenditures 35.9 31.2 4.6 Cash basis (including leases) Property, plants and equipment Depreciation 37.9 31.8 4.9 (including leases) R&D expenses 23.8 10.6 13.2 Main capital expenditures Segm

  8. Slide 8: 2. Forecasts for FY2012

    2. - Forecasts for FY2012 - [Appendix] 8 2012.05.21 Copyright © 2012 Meiji Holdings Co., Ltd. All rights reserved.

  9. Slide 9: Strategy and Business Plan: Key Points (Food Segment)

    Strategy and Business Plan: Key Points (Food Segment) ( Net sales: billions of yen) ( Op. income: billions of yen) Strategy Key Points 1,200 60 Execute business structure reforms to achieve 1,050.0 improved profitability and foster and strengthen new growth businesses. 988.8 986.3 1,000.0 1,000 50 1

  10. Slide 10: Strategy and Business Plan: Key Points (Dairy Business)

    Strategy and Business Plan: Key Points (Food Segment)  Dairy business Strategy Key Points ( Net sales: billions of yen) ( Op. income: billions of yen) Improve the profitability of mainstay businesses and 700 35 establish new businesses to strengthen our revenue base 627.9 (Actively face the challen

  11. Slide 11: Dairy Business: Sales of Mainstay Brands

    Strategy and Business Plan: Key Points (Food Segment)  Dairy Business: Sales of Mainstay Brands (billions of yen) FY2012 1st Half Full-year YoY change YoY change Meiji Oishii Gyunyu 25.9 +4.8% 49.7 +3.2% Meiji Bulgaria Yogurt 37.4 +12.7% 66.9 -3.1% Meiji Hokkaido Tokachi Cheese 5.3 +4.9% 11.2 +8.3%

  12. Slide 12: Strategy and Business Plan: Key Points (Confectionery Business)

    Strategy and Business Plan: Key Points (Food Segment)  Confectionery business Strategy Key Points ( Net sales: billions of yen) ( Op. income: billions of yen) - Recover profitability in the confectionery business 400 16 - Expand the scope of operations for desserts and other businesses that have si

  13. Slide 13: Strategy and Business Plan: Key Points (Healthcare and Nutritionals)

    Strategy and Business Plan: Key Points (Food Segment)  Healthcare and Nutritionals business ( Net sales: billions of yen) ( Op. income: billions of yen) Strategy Key Points 200 8 Implement business structure reforms with a focus on creating further synergies and strengthening profitability. 148.8 U

  14. Slide 14: Strategy and Business Plan: Key Points (Pharmaceuticals Segment)

    Strategy and Business Plan: Key Points (Pharmaceuticals Segment) ( Net sales: billions of yen) ( Op. income: billions of yen) Strategy Key Points 160 40 Quickly work to grow the business, overcome drug price revision, and achieve continual growth 140.0 - Strengthen fields where Meiji an advantage as

  15. Slide 15: FY2012: Capital Expenditures, Depreciation, R&D Expenses

    FY2012: Capital Expenditures, Depreciation, R&D Expenses (billions of yen) FY2012 Notes Food Pharma Capital 59.8 53.2 6.6 Cash basis (including leases) expenditures Property, plants and equipment Depreciation 38.2 31.6 5.3 (including leases) R&D expenses 24.5 11.0 13.5 Main capital expenditures Segm

  16. Slide 16: Forward-looking statements

     The forward-looking statements described in this material, such as business forecasts, are based on information available at the time of the release of this presentation and reasonable assumptions made by the Company. Actual results could differ materially from forecasts due to various factors. 

Meiji Holdings — FY2011 Earnings Presentation on 6ix